Using rTMS to treat mood and cognitive symptoms of depression
Official title: Multisite Repetitive Transcranial Magnetic Stimulation for Mood, Cognitive Impairment, Anhedonia and Disordered Sleep in Depressive Disorder
Run by Jagiellonian University · NCT06363981 · Data updated 2026-11-12
This study is testing if a new way of using brain stimulation can help improve mood and thinking problems in people with unipolar and bipolar depression who haven't found relief from regular treatments.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 90 (estimated) |
| Sponsor | Jagiellonian University Academic / other |
| Locations | 1 site (Krakow) |
| Status | Recruiting |
| Started | May 20, 2024 |
| Main results expected | December 2026 |
| Study ends | April 2027 |
| Registry record updated | October 15, 2024 |
| Trial ID | NCT06363981 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals experiencing moderate to severe depressive episodes without psychotic symptoms.
✕Probably not a fit
Patients with psychotic symptoms, recent suicidal ideations, or contraindications to rTMS will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effects of repetitive transcranial magnetic stimulation (rTMS) on mood, cognitive impairment, anhedonia, and sleep disorders in patients with unipolar depression and bipolar disorder. It aims to compare the therapeutic potential of multi-site stimulation over the left dorsolateral prefrontal cortex (DLPFC) and dorsomedial prefrontal cortex (dmPFC) against stimulation over the DLPFC alone and a sham treatment. The study includes patients with moderate to severe depressive episodes and assesses their symptoms using standardized scales. By exploring this novel approach, the study seeks to optimize rTMS as a treatment option for those who are resistant to conventional pharmacotherapy.
Why it matters
Potential benefit: If successful, this study could provide a new effective treatment option for patients suffering from depression and related cognitive impairments.
How similar studies have gone: While some studies have explored rTMS for depression, this multi-site approach is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * severe or moderate depressive episode (according to international classification of diseases (ICD)-10) without psychotic symptoms at the time of inclusion * Hamilton Depression Rating Scale between between 20 and 35 points at inclusion * The score in the Athens Insomnia Scale eight or more * The score of three or more points in items 4 and 21 of the Beck Depressions Inventory 2 * Complaining about problems with memory and concentration timely related with the onset of depression Exclusion Criteria: * Contraindications to transcranial magnetic stimulation, including ferromagnetic elements in head, pregnancy and epilepsy * Psychotic symptoms at the time of inclusion * Suicidal ideations and/or attempts within three months prior to inclusion
Where it's running
-
The Education of Research and Development Center, Babinski Clinical Hospital
Krakow, Poland Recruiting
Study contacts
- Principal investigator: Wojciech Korzeniowski, MD — The Education of Research and Development Center, Babinski Clinical Hospital
- Study coordinator: Wojciech Korzeniowski, MD
- Email: wojciech.korzen@gmail.com
- Phone: +48 12 652 45 20
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effects of theta burst stimulation on sleep and fatigue in depression
This study is testing if two types of brain stimulation can improve sleep and reduce tiredness in people with depression.
-
Effects of comorbidity on people with severe mental illness
This study tests how having both alcohol/substance use and a severe mental illness affects hospitalizations, medications, and social participation among adults followed at a mental health center.
-
Venous Tourniquet with Low-Dose Sugammadex vs Arterial Tourniquet for Seizure Monitoring During ECT
40 patients undergoing ECT will have a venous tourniquet on one arm and an arterial tourniquet on the other to see which method better reveals motor seizures.
-
7T MRI and visual perception markers for severe mood and psychotic disorders
This project tests whether 7‑tesla MRI scans combined with visual perception tests can identify brain markers linked to diagnosis and treatment outcomes in adults with major depressive disorder, bipolar disorder, or schizophrenia.
-
Emotional Eating, Sleep Quality, Mental State, and Metabolic Syndrome in Psychiatric Patients
This study tests how mood, sleep, and emotional eating relate to metabolic syndrome in people with schizophrenia or bipolar disorder.
-
À deux, c'est mieux — group program to improve romantic relationships for young adults with severe mental illness
This program will try a 12-week, small-group course to help single adults with severe mental illness build skills for dating, communication, and closer social relationships.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.